ACE Report Cover
Standard THA, large-head THA and RHA yield similar long-term functional outcomes
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
ARTHROPLASTY
Standard THA, large-head THA and RHA yield similar long-term functional outcomes .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2013;1(13):1 Acta Orthop. 2013 Jun;84(3):246-53. doi: 10.3109/17453674.2013.788435. Epub 2013 Mar 26

76 patients with primary osteoarthritis and secondary osteoarthritis due to mild dysplasia were randomized to receive either standard total hip arthroplasty (THA), large-head THA, or resurfacing hip arthroplasty (RHA) to examine the differences between these three treatments on long-term clinical function. Results at 2 years indicated that, although incision length and surgical time were significantly higher in the RHA group, there were no significant differences between groups in range of motion, Harris Hip scores (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, UCLA activity scores, step rate or sick leave. There was no clinically relevant difference between groups in quality of life.


Details zur Finanzierung der Veröffentlichung +
Finanzierung:
Non-Industry funded
Sponsor:
The Danish Ministry of the Interior and Health
Interessenkonflikte:
None disclosed

Risiko der Voreingenommenheit

5,5/10

Kriterien für die Berichterstattung

18/20

Fragilitäts-Index

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Ja = 1

Ungewiss = 0.5

Nicht relevant = 0

Nein = 0

Die Bewertung der Berichtskriterien bewertet die Transparenz, mit der die Autoren die methodischen und studienspezifischen Merkmale der Studie in der Veröffentlichung angeben. Die Bewertung ist in fünf Kategorien unterteilt, die im Folgenden vorgestellt werden.

4/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

Der Fragilitätsindex ist ein Instrument, das bei der Interpretation signifikanter Ergebnisse hilft und ein Maß für die Stärke eines Ergebnisses liefert. Der Fragilitätsindex gibt die Anzahl der aufeinanderfolgenden Ereignisse an, die zu einem dichotomen Ergebnis hinzugefügt werden müssen, damit das Ergebnis nicht mehr signifikant ist. Eine kleine Zahl steht für ein schwächeres Ergebnis und eine große Zahl für ein stärkeres Ergebnis.

Warum wurde diese Studie jetzt benötigt?

Previous research has found that large-head total hip arthroplasty (THA) or resurfacing hip arthroplasty (RHA) have several advantages when compared to standard THA, namely increased range of motion, decreased patient anxiety and reduced risk of dislocations. In addition, past literature has found that when compared to THA, RHA requires a larger incision, resulting in an immediate disadvantage but no long-term effect on function. However, in order to access the acetabulum, RHA also requires detachment of a section of gluteus maximus and this can cause long-term decreases in function. The present study aimed to compare the effects of standard THA, large-head THA and large-head RHA on long-term patient function.

Was war die wichtigste Forschungsfrage?

How did large-head RHA and THA compare to standard THA with respect to clinical function, when assessed at 2 years, in patients with primary and secondary osteoarthritis?

Merkmale der Studie +
Bevölkerung:
76 patients (age range: 40-65 years) with primary osteoarthritis and secondary osteoarthritis due to mild dysplasia.
Intervention:
RHA group (n=21): Patients in this group underwent resurfacing hip arthroplasty using an Articular Surface Replacement (ASR; DePuy, Leeds, UK) consisting of a high-carbon cobalt-chromium-molybdenum alloy. The median head size for this procedure was 51 mm (47-57mm). Their rehabilitation program consisted of full weight bearing in a home-based training program. Median age = 57 years (range 54-61); 40% female. Large-head THA (n=18): Patients in this group underwent total hip arthroplasty using M2aMagnum/ReCap articulation (made of cast high-carbon cobalt-chromium. The median head size for this procedure was 50 mm (44-56 mm). The stem was a cementless forged titanium Bimetric stem. Their rehabilitation program consisted of full weight bearing in a home-based training program. Median age = 63 years (range 54-64); 47% female.
Vergleich:
Standard THA (n=34): Patients at the Odense University Hospital underwent total hip arthroplasty using a Mallory Head acetabular shell with an Arcom Ringlock polyethylene liner. The head size used in this group was 28 mm. A Biolox delta modular ceramic head and a titanium Bimetric stem (Biomet, Bridge End, UK) were used at this center. Patients at Hospital South, Naestved underwent total hip arthroplasty using a cobalt-chromium head (28 mm), a titanium Trilogy CH cup and a VerSys Fiber titanium metal taper stem. The first 9 patients at this center received a Trilogy UHMWPE liner and the next 6 patients received a Longevity liner (Zimmer, Warsaw, IN). Their rehabilitation program consisted of full weight bearing in a home-based training program. Median age = 56 years (range 52-62); 29% female.
Ergebnisse:
Outcomes included range of motion, extension, the Harris Hip Score (HHS), the UCLA activity score, walking activity (assessed using the Yamax (YX200) pedometer), quality of life (assessed using the EQ-5D), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), surgical time, blood loss, length of incision, complications, hemoglobin levels and length of hospital stay.
Methoden:
RCT: Multi Center
Zeit:
Follow-up examinations were conducted at 8 weeks, 6 months, 1 year, and 2 years.
Was waren die wichtigsten Ergebnisse?
  • There was no significant difference between groups in blood loss (p=0.09), decrease in haemoglobin (p=0.50), length of hospital stay (p=0.80), flexion (p>0.05), internal rotation (p>0.05) and external rotation (p>0.05). Surgical time and incision length were significantly higher in the RHA group (p<0.001).
  • At 2 years, there was no significant difference in total range of motion between standard THA and large-head THA (p=0.60) or RHA (p=0.50).
  • Adduction, when measured at earlier time points, was significantly improved in the RHA group and large-head THA group, compared to standard THA at 8 weeks (p=0.02) and in the RHA group compared to the standard THA group at 6 months (p=0.03). At subsequent time points, no significant difference was observed between groups (p>0.05).
  • Although no significant differences observed at the earlier time points, there was a significant reduction in extension in the large-head THA group compared to the two other groups at 2 years (p<0.01). The same trend was observed in abduction in the RHA group (p=0.02 at 2 years in favour of the two THA groups).
  • At one year, all groups had received a HHS in the "excellent" category, with no significant differences between groups at 2 years (p>0.05). UCLA activity scores, WOMAC scores, and step rate were also not significantly different between groups at 2 years (p>0.05).
  • Quality of life was similar between groups up until the 2-year follow-up, with the large-head THA group obtaining significantly higher scores (p<0.05). There was no significant difference in sick leave between groups (p=0.80).
  • Complications included 1 cup displacement with dislocation and 1 suspected infection in the RHA group, 1 pulmonary embolus following a deep vein thrombosis and 1 incidence of pain and raised metal ion levels in the large-head THA group, as well as 3 dislocations in the standard THA group.
Was sollte ich mir besonders merken?

There were no significant differences between standard total hip arthroplasty (THA), large-head THA, or resurfacing hip arthroplasty (RHA) in range of motion, Harris Hip scores (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores, UCLA activity scores, step rate or sick leave, when assessed at 2 years. However, surgical time and incision length was significantly higher in the RHA group. Lastly, there was no clinically relevant difference in quality of life at 2 years.

Wie wird sich dies auf die Behandlung meiner Patienten auswirken?

The results from this study suggest that standard total hip arthroplasty (THA), large-head THA, and resurfacing hip arthroplasty (RHA) are all comparable treatments in the management of primary and secondary osteoarthritis. It is important to note that this study had a small sample size; although certain trends were observed in the data, it did not have enough power to detect any potential differences. Studies using larger sample sizes are necessary to conclusively determine if differences in clinical function exist between these three treatments. Furthermore, the metal ion concentrations due to the metal-on-metal nature of the resurfacing technique, as well as the adverse events associated with these increased concentrations should be considered when choosing a treatment option.

HAFTUNGSAUSSCHLUSS

Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.

0 von 4 monatliche KOSTENLOSE Artikel freigeschaltet
Sie haben Ihr Limit von 4 kostenlosen Artikeln in diesem Monat erreicht

Zugang zu OrthoEvidence für nur $1,99 pro Woche.

Bleiben Sie auf dem Laufenden mit den neuesten Beweisen. Jederzeit kündbar.
  • Kritische Beurteilungen der neuesten, hochwirksamen randomisierten kontrollierten Studien und systematischen Übersichten in der Orthopädie
  • Zugang zu OrthoEvidence-Podcast-Inhalten, einschließlich Kooperationen mit dem Journal of Bone and Joint Surgery, Interviews mit international anerkannten Chirurgen und Diskussionsrunden zu orthopädischen Neuigkeiten und Themen
  • Abonnement von The Pulse, einem zweimal wöchentlich erscheinenden evidenzbasierten Newsletter, der Ihnen helfen soll, bessere klinische Entscheidungen zu treffen
Upgrade
Close Dialog
Willkommen zurück!
Passwort vergessen?
Starten Sie Ihre KOSTENLOSE Testversion noch heute!

Ihr Konto ist verbunden mit
und umfasst den kostenlosen Zugang zu OrthoEvidence


ODER
Passwort vergessen?

ODER
Bitte überprüfen Sie Ihre E-Mail

Wenn ein Konto mit der angegebenen E-Mail-Adresse existiert, wird Ihnen eine E-Mail zum Zurücksetzen des Passworts zugesandt. Wenn Sie keine E-Mail sehen, überprüfen Sie bitte Ihren Spam- oder Junk-Ordner.

Für weitere Hilfe, kontaktieren Sie unser Support-Team.

Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Übersetzen ACE Report

OrthoEvidence nutzt einen externen Übersetzungsdienst, um Inhalte in mehreren Sprachen zugänglich zu machen. Bitte beachten Sie, dass trotz aller Bemühungen um Genauigkeit die Übersetzungen nicht immer perfekt sind.

Wie man dies zitiert ACE Report

OrthoEvidence. Standard THA, large-head THA and RHA yield similar long-term functional outcomes. OE Journal. 2013;1(13):1. Available from: https://myorthoevidence.com/AceReport/Show/standard-tha-large-head-tha-and-rha-yield-similar-long-term-functional-outcomes

Zitat kopieren
Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Premium-Mitglied-Funktion

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem Premium-Konto von OrthoEvidence angemeldet sein.

Teilen Sie dies ACE Report